Company Overview and News

0
Artemis Resources receives first approval for upgrade to Radio Hill gold processing plant capacity

2018-07-16 proactiveinvestors.com.au
Artemis Resources Ltd (ASX:ARV) has received the first of three key approvals for the installation of a new gold circuit at its Radio Hill processing plant in the Pilbara region of Western Australia.
ARV

0
Artemis Resources hits varied intrusive bodies in west Pilbara super-deep drill hole

2018-07-10 proactiveinvestors.com.au
Artemis Resources Ltd (ASX:ARV) (FRA:ATY) has observed several varied intrusion lithologies as it drills towards its super-deep vertical target of over 3,300 metres at ASD-1 in the west Pilbara.
ARV

2
Artemis and Novo JV announced $5.4m conglomerate gold exploration

2018-06-25 australianmining.com.au
Artemis Resources and Novo Resources will be injecting $5.4 million into further exploration and a work programme at the Karratha joint venture gold project.
NSRPF NVO ARV

2
Macarthur Minerals Completes Stream Sediment Sampling With Encouraging Results Within the Bonnie Scot Tenement in Pilbara, Western Australia

2018-06-13 globenewswire
VANCOUVER, British Columbia, June 13, 2018 (GLOBE NEWSWIRE) -- Macarthur Minerals Limited (TSX-V:MMS) (the “Company” or “Macarthur Minerals”) is pleased to announce that it has completed a sediment sampling program at its Bonnie Scot tenement in the Pilbara region of Western Australia (“Bonnie Scot”) with encouraging results. During the geochemical survey a total of 45 samples were collected from selected drainage courses across the tenement area.
NSRPF NVO MMSDF ARV

3
Kirkland Lake Gold Completes Acquisition of Shares of Novo Resources Corp.

2018-05-30 globenewswire
TORONTO, May 30, 2018 (GLOBE NEWSWIRE) -- Kirkland Lake Gold Ltd. (“Kirkland Lake Gold” or the “Company”) (TSX:KL) (NYSE:KL) (ASX:KLA) today announced that, further to the Company’s press release dated May 10, 2018, the Company has completed the acquisition of 4,000,000 common shares (the “Shares”) of Novo Resources Corp. (“Novo”). Pursuant to the share purchase agreement entered into between the Company and Artemis Resources Ltd.
KGI NSRPF KGI.DB.A KGI.DB NVO KL ARV

2
Artemis recovers more Pilbara gold nuggets

2018-05-29 australianmining.com.au
Artemis Resources has submitted a programme of works (POW) with the Western Australian mines department to launch extensive drilling, trenching and bulk sampling at the Comet Well West conglomerate gold project in the Pilbara.
NSRPF NVO ARV

2
Impact Minerals secures option to acquire conglomerate-hosted gold project

2018-05-29 proactiveinvestors.com.au
Impact Minerals Ltd (ASX:IPT) has acquired an option to purchase 95% of an advanced conglomerate-hosted gold project in central Queensland.
PACXF NSRPF IPT NVO ARV

4
Artemis offloads Novo stake to Kirkland Lake

2018-05-13 australianmining.com.au
Artemis Resources is selling its stake in Novo Resources to Canadian miner Kirkland Lake Gold for $20.7 million.
KGI NSRPF KGI.DB.A KGI.DB NVO KL ARV

3
Novo Reports Planned Share Transaction Between Kirkland Lake Gold and Artemis Resources

2018-05-11 globenewswire
VANCOUVER, British Columbia, May 11, 2018 (GLOBE NEWSWIRE) -- Novo Resources Corp. (“Novo” or the “Company”) (TSX-V:NVO) (OTCQX:NSRPF) reports that it has conditionally agreed to lift the remainder of a twelve-month contractual hold period in order to permit the purchase by Kirkland Lake Gold of 4 million Novo common shares which were issued to Artemis Resources in August 2017 (please see the Company’s news release dated August 15, 2017).
KGI NSRPF KGI.DB.A KGI.DB NVO KL ARV

2
Artemis sells off $20m Novo stake

2018-05-11 businessnews.com.au
Artemis Resources has announced plans to sell its stake in Canadian joint venture partner Novo Resources for $20.7 million, with the proceeds set to be spent on exploration at the company’s conglomerate gold assets in the Pilbara.
NSRPF NVO ARV

3
Kirkland Lake Gold Enters Into Agreement to Acquire Shares of Novo Resources Corp.

2018-05-11 globenewswire
TORONTO, May 10, 2018 (GLOBE NEWSWIRE) -- Kirkland Lake Gold Ltd. (“Kirkland Lake Gold” or the “Company”) (TSX:KL) (NYSE:KL) (ASX:KLA) is pleased to announce that it has entered into a share purchase agreement with Artemis Resources Limited (“Artemis”) to acquire 4,000,000 common shares (the “Shares”) of Novo Resources Corp. (“Novo”) at a price of C$5.00 per Share for a total purchase price of C$20,000,000 (the “Acquisition”).
KGI NSRPF KGI.DB.A KGI.DB NVO KL ARV

0
Artemis Resources drills grades of up to 11.15% nickel

2018-05-03 proactiveinvestors.com.au
Artemis Resources Ltd (ASX:ARV) has received its first assays from initial reverse circulation (RC) drilling at the Ruth Well Nickel Copper Cobalt Project in Western Australia.
ARV

0
Artemis showcases Pilbara gold nuggets ahead of ‘serious exploration’

2018-04-18 australianmining.com.au
Artemis Resources’ plan to launch an exploration program on the 47K Patch gold-bearing conglomerates in the Pilbara has been approved by the Western Australian mines department.
ARV

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to ASX:ARV / ARTEMIS RESOURCES LIMITED on message board site Silicon Investor.

Marvell Technology Group {MRVL} Marvel Entertainment (MRV) - Turnaround in Sight!
Harvard Apparatus Regenerative Technology The Darvas Box Thread - Using the Nicholas Darvas system
Darvas Darvas Trading Method
VGEN: Harvard Scientific (formerly HVSF) HRVE - Harvey Electronics, Inc.
Marvel Enterprises (NYSE) The Blandbutmarvellous Official Notices Board